{"id":499798,"date":"2021-06-01T06:33:51","date_gmt":"2021-06-01T10:33:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/"},"modified":"2021-06-01T06:33:51","modified_gmt":"2021-06-01T10:33:51","slug":"springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/","title":{"rendered":"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>STAMFORD, Conn., June  01, 2021  (GLOBE NEWSWIRE) &#8212; SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will participate in a Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8th at 3:00PM ET.<\/p>\n<p>To access the live webcast please visit the Events &amp; Presentations page within the Investors &amp; Media section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_Y--Cuk29yVr3Q2Q32vFQnKp_SBHUUJi94OL-l3-dlTpd6HrvmGiAB-1ivAJpU7hgYEkr5G26ENc3WxybTbgwKJ8uUxH4Xxjx8YHNEQ4hXY=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.springworkstx.com<\/a>. A replay of the webcast will be available on SpringWorks\u2019 website for a limited time following the conference.<\/p>\n<p>\n        <strong>About SpringWorks Therapeutics<\/strong><br \/>\n        <br \/>SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for patients living with severe rare diseases and cancer. SpringWorks has a differentiated targeted oncology portfolio of small molecule product candidates and is advancing two potentially registrational clinical trials in rare tumor types as well as several other programs addressing highly prevalent, genetically defined cancers. SpringWorks\u2019 strategic approach and operational excellence in clinical development have enabled it to rapidly advance its two lead product candidates into late-stage clinical trials while simultaneously entering into multiple shared-value partnerships with innovators in industry and academia to expand its portfolio to create more solutions for patients with cancer. For more information, visit\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gYLsElNVPw8MMiiXjc5UCZt4Z7Cg7Bvp8h3XWKyXyeXbhVgC76JKYX2EY2-nTURndV7s3cH2VFfApXkJqLeYj6OCNeYRgT7sAkNjMVG8ovM=\" rel=\"nofollow noopener\" target=\"_blank\">www.springworkstx.com<\/a><\/u>\u00a0and follow @SpringWorksTx on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NeZ_K-8OLMIfxv1T6fI3dbI-Vdu8coxebIoLVgA_amXWtZ5MP4fUkdO_5b8r-IyRugA4YQcHbYYGQVFqW8Hbqw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>Twitter<\/u><\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ytPY_QKcI3gk_86UEkCodpJEVsfvmKWoxHp2AuYBYA4TDA-3poYdZzbtMsOsOzU25nv-p0YQ4EDkwfIYSove_9_7y2JcwAGhr2HGIEANoKoUOj_bDURj6DDZNk4ath8_\" rel=\"nofollow noopener\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.\u00a0<\/p>\n<p>\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Kim Diamond<br \/>Phone: 203-561-1646<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4nW-0OwuDBRvKBJ18NAtQi3zRUF18ZlB66jeVlpYIVusidQxFwPi-NNZD7Wl_iizt8jWbMqU2OOblBOaBG37UTJl5HTA7pb0TLrO9XPBSjrznVckLv2SL2U6ixaY3fLO\" rel=\"nofollow noopener\" target=\"_blank\">kdiamond@springworkstx.com<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/02742e4c-ad95-4339-86f8-1d603f8dee29\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>STAMFORD, Conn., June 01, 2021 (GLOBE NEWSWIRE) &#8212; SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will participate in a Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8th at 3:00PM ET. To access the live webcast please visit the Events &amp; Presentations page within the Investors &amp; Media section of the company\u2019s website at https:\/\/ir.springworkstx.com. A replay of the webcast will be available on SpringWorks\u2019 website for a limited time following the conference. About SpringWorks Therapeutics SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-499798","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STAMFORD, Conn., June 01, 2021 (GLOBE NEWSWIRE) &#8212; SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will participate in a Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8th at 3:00PM ET. To access the live webcast please visit the Events &amp; Presentations page within the Investors &amp; Media section of the company\u2019s website at https:\/\/ir.springworkstx.com. A replay of the webcast will be available on SpringWorks\u2019 website for a limited time following the conference. About SpringWorks Therapeutics SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for &hellip; Continue reading &quot;SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-01T10:33:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference\",\"datePublished\":\"2021-06-01T10:33:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\"},\"wordCount\":251,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\",\"name\":\"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=\",\"datePublished\":\"2021-06-01T10:33:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk","og_description":"STAMFORD, Conn., June 01, 2021 (GLOBE NEWSWIRE) &#8212; SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will participate in a Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8th at 3:00PM ET. To access the live webcast please visit the Events &amp; Presentations page within the Investors &amp; Media section of the company\u2019s website at https:\/\/ir.springworkstx.com. A replay of the webcast will be available on SpringWorks\u2019 website for a limited time following the conference. About SpringWorks Therapeutics SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for &hellip; Continue reading \"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-01T10:33:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference","datePublished":"2021-06-01T10:33:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/"},"wordCount":251,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/","name":"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=","datePublished":"2021-06-01T10:33:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0NTMzOSM0MjA3Nzk5IzIxODQ0ODA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/springworks-therapeutics-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=499798"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/499798\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=499798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=499798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=499798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}